Citation Tools
PDFRegular and young investigator award abstracts
Cellular therapies
145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment